Unknown NA INTERVENTIONAL 2-arm
NCT00804115
The International Collaborative Exfoliation Syndrome Treatment Study
Sponsor: Pfizer
Conditions
Exfoliation Syndrome Glaucoma Ocular Hypertension
Interventions
Latanoprost with Pilocarpine vs Timolol or Cosopt
Updated 4 times since 2017 Last updated: Dec 5, 2008 Started: Aug 31, 2000 Primary completion: Sep 30, 2007 Completion: Dec 31, 2008
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Exfoliation Syndrome and Glaucoma, this trial is ongoing. The trial is conducted by Pfizer and has accumulated 4 data snapshots since 2000. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jan 2017 — Jan 2021 [monthly]
Unknown Status NA
First recorded
Aug 2000
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Pfizer
- The New York Eye & Ear Infirmary
Data source: The New York Eye & Ear Infirmary
For direct contact, visit the study record on ClinicalTrials.gov .